首頁 > 市場調查報告書 > 製藥

開發平台分析

市場調查報告書

商品編碼

1392044

巨噬細胞標記物市場：按標記物類型、按應用、按疾病領域、按最終用戶、按地區

Macrophage Marker Market, By Marker Type, By Application, By Disease Area, By End User, By Geography

出版日期: 2023年11月01日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023年，全球巨噬細胞標記物市值為2.562億美元，預計2030年將達到3.982億美元，2023年至2030年的年複合成長率為6.5%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	2.562 億美元
實績資料	2018-2021	預測期	2023-2030
預測期年複合成長率	6.50%	2030年市場規模預測	3.982 億美元

圖 1. 2023 年按地區分類的巨噬細胞標記物的全球市場佔有率(%)

巨噬細胞是白血球，在免疫和體內平衡中發揮重要作用。巨噬細胞充當吞噬異物、微生物和碎片的第一個響應者。由於巨噬細胞的重要性，因此有必要進行表徵和研究巨噬細胞的生物學。巨噬細胞標記使研究人員能夠識別、分離、追蹤和標靶化這些細胞。巨噬細胞標記物有兩種主要類型。一種是細胞表面標誌物，一種在巨噬細胞外膜上表現的蛋白質，可以使用螢光活化細胞分選或免疫組織化學進行檢測。常見的巨噬細胞表面標誌物包括 CD68、CD14、CD163 和 CD206。另一種是細胞內標記物，它是巨噬細胞內存在的蛋白質。

細胞內標記提供有關巨噬細胞活化和功能的資訊，但需要固定和通透細胞。細胞表面標誌物的優點是可以進行活細胞分析、分離和標靶化巨噬細胞。然而，沒有足夠特異性的標記來唯一識別巨噬細胞，標記表達根據活化狀態和組織環境而變化。理想情況下，多種標記物的組合對於準確表徵巨噬細胞表現型和群體是理想的。全球市場提供了多種針對巨噬細胞標記物的單株抗體，這些抗體可用於基礎和應用研究，以尋找針對任何疾病狀態的新治療策略。

市場動態

免疫學研究的增加、慢性病盛行率的增加、技術進步和個人化醫療方法是預計在預測期內推動全球巨噬細胞標記物市場成長的主要因素。

例如，國家生物技術資訊中心2022年6月發布的一份報告發現，印度約有21%的老年人至少患有一種慢性病。

同時，根據國際癌症控制聯盟2020年12月發布的報告，全球整體每5個人中就有1人會在一生中罹患癌症，其中8分之一的男性和11分的女性，每人就有1人死於癌症。

然而，巨噬細胞異質性的複雜性、特異性和敏感性的缺乏以及有效抗體的有限可用性預計將阻礙預測期內全球巨噬細胞標記物市場的成長。

本研究的主要特點

本報告對全球巨噬細胞標記物市場進行了詳細分析，並列出了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率。
它還揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
該報告根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球巨噬細胞標記物市場的主要企業。
該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
全球巨噬細胞標記物市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球巨噬細胞標記物市場的各種策略矩陣，將有助於相關人員做出決策。

北美洲
美國
加拿大
歐洲
德國
英國
西班牙
法國
義大利
俄羅斯
其他歐洲國家
亞太地區
中國
印度
日本
澳洲
韓國
ASEAN
其他亞太地區
拉丁美洲
巴西
阿根廷
墨西哥
其他拉丁美洲
中東
海灣合作理事會國家
以色列
其他中東地區
非洲
南非
北非
中部非洲

第10章競爭形勢

Abcam plc
Bio-Rad Laboratories, Inc.
Cell Signaling Technology, Inc.
BD Biosciences
Thermo Fisher Scientific, Inc.
Agilent Technologies, Inc.
BioLegend, Inc.
Merck KGaA
Novus Biologicals, LLC
R&D Systems, Inc.（a Bio-Techne brand）
Santa Cruz Biotechnology, Inc.
Beckman Coulter, Inc.
Miltenyi Biotec GmbH
GeneTex, Inc.
MBL International Corporation

第11章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI5945

The Global Macrophage Marker Market was valued at US$ 256.2 million in 2023 and is projected to reach US$ 398.2 million by 2030, at a CAGR of 6.5% from 2023 to 2030.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 256.2 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	6.50%	2030 Value Projection:	US$ 398.2 Mn

Figure 1. Global Macrophage Marker Market Share (%), By Region, 2023

Macrophages are white blood cells that play a key role in immunity and homeostasis. They act as first responders, ingesting foreign materials, microbes, and debris. Due to their importance, it is essential to characterize and study macrophage biology. Macrophage markers allow researchers to identify, isolate, track, and target these cells. There are two main types of macrophage markers. The first are cell surface markers, which are proteins expressed on the outer membrane of macrophages that can be detected using fluorescence-activated cell sorting or immunohistochemistry techniques. Common macrophage cell surface markers include CD68, CD14, CD163, and CD206. The second type are intracellular markers, which are proteins located inside macrophage cells.

Intracellular markers provide information about macrophage activation and function but require fixed and permeabilized cells. Cell surface markers have the advantage of allowing live cell analysis, isolation, and potentially targeting of macrophages. However, no single marker is specific enough to uniquely identify macrophages, and marker expression can change depending on activation state and tissue environment. Ideally, a combination of several markers is used to accurately characterize macrophage phenotypes and populations. The global market offers a wide variety of monoclonal antibodies against macrophage markers, aiding fundamental and applied research seeking new treatment strategies across medical conditions.

Market Dynamics

Increasing research in immunology, the growing prevalence of chronic diseases, technological advancements, and personalized medicine approaches are major factors expected to drive growth of the global macrophage marker market during the forecast period.

For instance, in June 2022, according to a report published by the National Center for Biotechnology information, approximately 21% of the elderly in India reportedly have at least one chronic disease.

While, in December 2020, according to a report published by the Union for International Cancer Control, globally, 1 in 5 people develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women die from the disease.

However, the complexity of macrophage heterogeneity, a lack of specificity and sensitivity, and the limited availability of validated antibodies are expected to hamper growth of the global macrophage marker market over the forecast period.

Key features of the study:

This report provides in-depth analysis of the global macrophage marker market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global macrophage marker market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abcam plc, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., BD Biosciences, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., BioLegend, Inc., Merck KGaA, Novus Biologicals, LLC, R&D Systems, Inc. (a Bio-Techne brand), Santa Cruz Biotechnology, Inc., Beckman Coulter, Inc., Miltenyi Biotec GmbH, GeneTex, Inc., MBL International Corporation.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global macrophage marker market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global macrophage marker market

Global Macrophage Marker Market Detailed Segmentation:

By Marker Type:
- CD68
- CD163
- CD206
- CD14
- CD11b
- CD64
- CD11c
- Others
By Application:
- Research Use
- Diagnostic Use
- Drug Development
By Disease Area:
- Oncology
- Infectious Diseases
- Autoimmune Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Others
By End User:
- Research Institutes and Academic Centers
- Pharmaceutical and Biotechnology Companies
- Clinical and Diagnostic Laboratories
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Top companies in Global Macrophage Marker Market
- Abcam plc
- Bio-Rad Laboratories, Inc.
- Cell Signaling Technology, Inc.
- BD Biosciences
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- BioLegend, Inc.
- Merck KGaA
- Novus Biologicals, LLC
- R&D Systems, Inc. (a Bio-Techne brand)
- Santa Cruz Biotechnology, Inc.
- Beckman Coulter, Inc.
- Miltenyi Biotec GmbH
- GeneTex, Inc.
- MBL International Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Macrophage Marker, By Marker Type
- Market Macrophage Marker, By Application
- Market Macrophage Marker, By Disease Area
- Market Macrophage Marker, By End User
- Market Macrophage Marker, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Macrophage Marker Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Macrophage Marker Market, By Marker Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
CD68
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
CD163
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
CD206
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
CD14
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
CD11b
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
CD64
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
CD11c
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Global Macrophage Marker Market, By Application, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Research Use
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Diagnostic Use
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Drug Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

7. Global Macrophage Marker Market, By Disease Area, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

8. Global Macrophage Marker Market, By End User, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Research Institutes and Academic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Clinical and Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

9. Global Macrophage Marker Market, By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019-2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Marker Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Area, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Marker Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Area, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Marker Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Area, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Marker Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Area, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Marker Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Area, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Marker Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Area, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Mn)
South Africa
North Africa
Central Africa

10. Competitive Landscape

Abcam plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories, Inc.
Cell Signaling Technology, Inc.
BD Biosciences
Thermo Fisher Scientific, Inc.
Agilent Technologies, Inc.
BioLegend, Inc.
Merck KGaA
Novus Biologicals, LLC
R&D Systems, Inc. (a Bio-Techne brand)
Santa Cruz Biotechnology, Inc.
Beckman Coulter, Inc.
Miltenyi Biotec GmbH
GeneTex, Inc.
MBL International Corporation
Analyst Views

11. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

集落刺激因子（CSF）治療市場：現況分析與預測（2024-2032）

FAQ

巨噬細胞標記物市場：按標記物類型、按應用、按疾病領域、按最終用戶、按地區